Financial Highlights

Year ended or at December 31
(in millions, except per share data and notional value) 2015 2014 Change

1Amounts exclude cash performance bonds and guaranty fund contributions.

22011 results include a $646 million non-cash benefit from a tax adjustment primarily due to a revaluation of our deferred tax liabilities.

All references to volume, open interest and notional value in the text of this document exclude our CDS and IRS contracts.

See the 2015 Annual Report on Form 10-K for the company's forward-looking statements and risk factors.

Income Statement Data
Total revenues $3,327 $3,113 7%
Operating income 1,989 1,768 12
Income before income taxes 1,957 1,771 10
Net income attributable to CME Group  1,247 1,127 11
Earnings per share:
Basic  $3.71 $3.37 10%
Diluted  3.69 3.35 10
Balance Sheet Data
Current assets1 $2,351 $1,979 19%
Total assets1 31,818 31,675 -
Current liabilities1 1,271 964 32
Total liabilities1 11,267 10,751 5
CME Group shareholders' equity 20,552 20,923 (2)
Other Data
Total contract volume (round turn trades) 3,533 3,443 3%
Total electronic volume (round turn trades) 3,083 2,975 4
Open interest at year end (contracts) 91 94 (2)
Notional value of trading volume (in trillions) $1,167 $1,161 -
Total Contract Volume: 11 - 3,387; 12 - 2,890; 13 - 3,161; 14 - 3,443; 15 - 3,533

Total Contract Volume

(in millions of round turn trades)

Total Revenues: 11 - 3,281; 12 - 2,915; 13 - 2,936; 14 - 3,113; 15 - 3,327

Total Revenues

(in millions of dollars)

Net Income Attributable to CME Group: 11 - 1,812; 12 - 896; 13 - 977; 14 - 1,127; 15 - 1,247

Net Income Attributable to CME Group2

(in millions of dollars)

Dividends Declared: 11 - 1.12; 12 - 3.70; 13 - 4.40; 14 - 3.88; 15 - 4.90

Dividends Declared

(in dollars per share)

Continue to: Company Achievements in 2015